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CHAPTER 1  
 
THE LEFTY PRODOMAIN REGULATES LEFTY FUNCTION 
Introduction 
 Embryogenesis is dependent on signaling ligands that instruct cells to migrate and 
differentiate into their respective fates. This process gives the embryo the capacity to give 
rise to a complete organism from a small pool of resources. How can an organism 
accomplish this process? An embryo is able to amplify the effects of a small number of 
signaling pathways. One such cell-signaling pathway that plays a prominent role in early 
vertebrate development is the Nodal-signaling pathway. 
Nodal: Member of the TGFβ Superfamily 
 Nodal is a member of a large family of signaling molecules called the 
Transforming Growth Factor Beta (TGFβ) superfamily of secreted ligands (Schier, 2003). 
The TGFβ superfamily members function by sending extracellular signals to the cell 
nucleus via a cascade of intracellular components that then regulate the transcription of 
target genes. This pathway requires two receptors for signaling: a type I receptor and a 
type II receptor, both serine/threonine kinases. The type II receptors are constitutively 
active and phosphorylate and activate type I receptors when brought into close proximity 
by ligand interaction (Hill, 2001). Signals from the receptors are transduced to the 
nucleus via the phosphorylation of intracellular signaling proteins called smads (Hill, 
2001). Once activated, the smads form complexes and accumulate in the nucleus where 
they are directly responsible for transcriptional activation [see figure 1] (Hill, 2001). 
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Figure 1. The Nodal-signaling pathway.   
1. The secreted ligand Nodal interacts with its obligate co-receptor EGF-CFC and binds 
to the Type II constitutive serine – threonine transmembrane receptor. 2. Type II then 
phosphorylates the type I receptor thereby activating it. 3. This receptor in turn 
phosphorylates intracellular smad which complexes with a co-smad. 4. This smad 
complex is then translocated inside the nucleus to promote response genes’ 
transcription.  
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Lefty Negatively Regulates Nodal  
 Because Nodal signaling shares pathway components with other members of the 
TGFβ superfamily, there needs to be a mechanism that regulates Nodal signaling. Lefty, 
an atypical member of the TGFβ superfamily has been identified to function as the 
principal antagonist of the Nodal-signaling pathway. Studies have shown that Lefty is 
responsible for regulating the Nodal-signaling pathway by two possible mechanisms. The 
first is by interacting with Nodal itself and the second is by interacting with the EGF-
CFC obligate Nodal co-receptor [see fig 2] (Chen and Shen, 2004).  
The Effects of Lefty and Nodal Dysfunctional Signaling in Xenopus laevis 
 Previous work in Xenopus has shown that without Lefty function, Nodal is left 
unregulated and this leads to severe embryo perturbations known as exogastrulation 
(Branford and Yost, 2002; Cha et al., 2006). An exogastrulated embryo is observed as 
developing "inside-out". The tissue that normally lies within the embryo and under its 
skin extends outwards while the pigmented epidermis that normally covers the exterior of 
the embryo remains crumpled-up at the other extreme end of the developing embryo. 
These phenotypes are a result of excess endoderm and mesoderm formation as shown by 
phenotypic and in situ hybridization studies (Branford and Yost, 2002). A rescue of this 
phenotype was obtained by co-injecting Xlefty DNA with the anti-Xlefty morpholino 
(Branford and Yost, 2002). Based on these observations Lefty's function as the principal 
Nodal antagonist is very important since dysregulated Lefty signaling leads to an embryo 
that is incapable of undergoing proper development. 
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Figure 2. Two modes by which Lefty blocks the Nodal-signaling 
cascade.  
1. Lefty antagonizes Nodal by directly interacting with it and thus 
preventing Nodal from signaling. 2. Lefty interacts with the EGF-CFC 
Nodal obligate co-receptor, which results in Nodal’s inability to signal. 
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TGFβ regulation by proteolysis 
 Post-translational modification is widespread for members of the TGFβ 
superfamily and presents a method of regulation (Freeman and Gurdon, 2002). Some 
members of this signaling family are secreted as inactive pro-proteins which are then 
processed by different species of proteases to release regulation so they can then function 
(Freeman and Gurdon, 2002). There is currently evidence for cleavage both prior and 
after secretion. For example, Nodal and Lefty are thought to be secreted as inactive pro-
proteins and become active in the presence of proteases from the SPC superfamily (Ben-
Haim et al., 2006; Constam and Robertson, 2000a; Sakuma et al., 2002; Westmoreland et 
al., 2007). Here we isolated the prodomain from the mature Xlefty so that we can 
elucidate the mechanisms that govern Lefty regulation by the prodomain.  
The Xenopus Lefty (Xlefty) Prodomain 
 The Xlefty prodomain was isolated and tested in microinjection studies to 
elucidate the mechanisms that govern Lefty regulation by the prodomain. The Xlefty 
protein contains two consensus R-X-X-R cleavage sites that are acted upon by the 
calcium-dependent serine endoproteases of the subtilisin-like proprotein convertase 
family (SPCs) [see figure 3 and 4] (Westmoreland et al., 2007). These SPC sites are 
found in many intercellular signaling molecule pro-proteins, an example being Nodal.  
Cleavage at these sites releases the prodomain (PD) region from the mature Xlefty (Mat-
Xlefty) protein (Fig. 4) (Sakuma et al., 2002; Westmoreland et al., 2007). Removal of the 
Lefty prodomain has been shown to be a prerequisite for normal functionality (Sakuma et 
al., 2002; Westmoreland et al., 2007). When an Xlefty cleavage mutant is made by 
mutating the two potential cleavage sites into non-cleavable sites, this mutated Xlefty 
derivative is unable to block Nodal in a frog animal cap assay (Sakuma et al., 2002; 
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Westmoreland et al., 2007). For Lefty to function, cleavage of its prodomain is required 
yet there has been no study into what mechanism is used by the prodomain to regulate 
Lefty activity. The prodomains of other TGFβs have been shown to play roles in protein 
folding and stability, sequestration of inactive protein and regulation of signaling 
(Constam and Robertson, 1999, 2000a, b). The work presented here seeks to elucidate 
roles that the Lefty prodomain plays in regulating Lefty activity. Our studies into the 
Lefty prodomain considered recent evidence of TGFβ architecture where crystal 
structures revealed a novel fold for the prodomain that showed how the prodomain 
shields the growth factor from recognition by receptors and alters its conformation (Shi et 
al., 2011). This "strait-jacket" like conformation suggested that the domain at the C-
terminus folds with or subsequent to the N-terminal prodomain (Shi et al., 2011). 
Additionally, since the Lefty protein is cleaved at the first cleavage site this would allow 
release of the straight-jacket and would be sufficient to enable access to growth factor 
domains (Shi et al., 2011). Our hypothesis has been that the Lefty prodomain is able to 
interact with the mature Lefty domain and thus folds the molecule into an inactive state. 
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Figure 3. The Xlefty molecule. 
Graphic depicting the approximate location of the predicted signal 
sequence (SS) site before the prodomain (PD), the consensus RKRR 
cleavage site and the second consensus RFHR cleavage site. PD stands for 
the prodomain which was studied in this work to determine its function in 
Lefty activity. 
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Figure 4. Xlefty proteolytic processing. 
In “A” the schematic represents what is known about Xlefty processing and function.  
Briefly, the Xlefty prodomain is cleaved by subtilisin-like proprotein convertases (SPCs) 
which allow the mature ligand to function by blocking Nodal signaling either by 
interacting with Nodal itself or its obligate co-receptor Cripto. We hypothesize in “B” that 
the PD is most likely preventing Xlefty activity by interacting with the mature Xlefty 
ligand in either a pre-cleavage complex or a post-cleavage complex. There is also a 
possibility that it may interact with both a pre- and post-cleavage Xlefty. 
A B 
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Insights into the Xlefty prodomain function 
 In this study, we utilized multiple Xlefty prodomain-related mutants to elucidate 
Lefty-prodomain regulatory mechanisms. Here we show that the Xlefty prodomain when 
over-expressed in Xenopus gastrula stage embryos results in exogastrulation. This 
phenotype has been shown by our lab to occur when Xlefty function is disrupted 
(Branford and Yost, 2002). This result led us to postulate that like other members of the 
TGFβ superfamily the Lefty prodomain has the capacity to interact molecularly with the 
mature portion of the growth factor and inhibits its function. This was then confirmed by 
co-immunoprecipitation (co-IP) and rescue studies. The prodomain is able to co-IP full 
length mature Xlefty (Mat-Xlefty) but a prodomain with mutated amino acids is unable to 
co-IP full length Mat-Xlefty. These results allowed us to propose a model in which the 
prodomain intramolecularly interacts with mature Lefty in order to regulate Lefty 
activity. Secretion studies implementing both an embryo and cell culture assay system 
were done on Xlefty and its mutated derivatives, including a prodomain-less Lefty 
(PDL), Lefty cleavage mutants (LCM), and a prodomain mutated Lefty (PDmut) and its 
derivatives. The collective results of our secretion studies led us to report on another 
function that the prodomain plays in Lefty regulation. It may regulate Lefty function by 
playing a role in proper Lefty secretion. The mutated Xlefty clones were not present in 
the secreted medium compared to wild-type Xlefty, which had secreted Mat-Xlefty in the 
secreted medium. This led us to hypothesize that the prodomain facilitates the secretion 
machinery to secrete the Lefty mature growth factor properly. Taken together these 
results show for the first time regulatory mechanisms of Lefty function by its prodomain.  
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Results 
PD microinjection causes left-right abnormalities at lower concentrations 
and exogastrulation at higher amounts.  
 Studies have shown that without the cleavage of the prodomain Lefty is unable to 
perform its function normally (Beck and Slack, 2001; Sakuma et al., 2002; Westmoreland 
et al., 2007). Our hypothesis was that the Lefty PD negatively regulates Lefty by 
molecularly interacting with it. Thus we predicted that over-expression of the PD would 
antagonize Lefty functionality. The PD corresponds to the 77 amino acid N-terminal 
sequence and the first 24 amino acids of the PD are predicted to be the signal sequence 
that is presumably cleaved from Xlefty in the endoplasmic reticulum. The remaining PD 
is cleaved from Xlefty by SPC proteases to release mature Xlefty. We tested the ability of 
PD to antagonize the normal functionality of Xlefty by microinjecting increasing 
amounts of PD into the cells of a 4 cell stage embryo. First, a concentration of 500 pg of 
PD mRNA was microinjected into each blastomere of a 4-cell stage embryo. This 
resulted in embryos having left-right defects, which are observed in an Xlefty mis-
expression context (Fig.5) (Branford et al., 2000). An adapted scoring format previously 
designed by our lab was used to assess the presence of reversed hearts and the presence 
of reversed guts or guts having heterotaxia (Branford et al., 2000). At stage 45 and 
onwards the left-right asymmetry was assessed by observing the looping of the ventricle 
and the conotruncus (ct) in the three-chambered heart of the embryo (Branford et al., 
2000). In normal embryos, the ct loops to the left whilst the ventricle is positioned to the 
right with the reverse orientation seen in reversed hearts. Coiling of the primitive gut 
commences at stage 43 and fully coils by stage 45 (P.D. Nieuwkoop, 1967). At stage 46, 
the orientation of the gut was assessed by its morphology and by the following scoring 
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system. The system used to score left-right morphogenesis of the gut looks at two 
features defined as “coil origin” and “coil direction”. In normal embryos, the gut coil 
origin enters the abdominal cavity on the right side of the body and is referred to as the 
right origin (RO) (Branford et al., 2000).  The coil direction refers to whether the coils 
spiral clockwise or counterclockwise when viewed ventrally (Branford et al., 2000). In 
normal embryos, the gut coils in a counterclockwise (CCW) manner. In this scoring 
system, a normal embryo has a normal heart and a gut with right origin (RO) and 
counterclockwise coiling (CCW) {RO-CCW}. A completely reversed embryo would 
have a reversed heart and a gut with left origin (LO) and clockwise coiling (CW). Other 
embryos were seen to express heterotaxic guts. Organs expressing heterotaxia have 
abnormal positioning within the organism that are not seen in normal situs without 
having total situs inversus (Branford et al., 2000). In embryos with heterotaxia the gut 
origin and gut coiling were not considered a full reversal and may be of RO-CCW or LO-
CCW orientation (Branford et al., 2000).  
 Forty-six percent of the embryos injected with the PD had reversed hearts 
(Fig.6a). Thirty-one percent had gut heterotaxia, while 12% had full gut reversals 
(Fig.6b). Lefty is the principal antagonist of Nodal, therefore our results are consistent 
with the idea that the prodomain negatively regulates Lefty since randomization of left-
right asymmetry was seen when Xlefty function was blocked (Branford et al., 2000). This 
led us to increase the concentration of PD being microinjected into the embryo to 1ng/cell 
at the 4-cell stage to see if we could elicit more phenotypes consistent with Xlefty over-
expression. Surprisingly, we observed a spectrum of phenotypes at this concentration 
(Fig. 7). This spectrum included 100% dorsal closure, less than 50% dorsal closure, more 
than 50% dorsal closure and exogastrulation. The results showed that 60% (n=97) of PD-
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microinjected embryos resulted in exogastrulae, while 98% (n=98) of uninjected embryos 
were normal (Fig. 8). Our lab previously demonstrated that when the function of Xlefty is 
blocked using an anti-Xlefty morpholino, this resulted in exogastrulation (Branford and 
Yost, 2002). An exogastrula is an embryo that has developed inside out. This phenotype 
has also been observed when Nodal, Xlefty’s primary target, is over-expressed (data not 
shown). The gradual loss of dorsal closure observed in the embryos and the presence of 
exogastrula led us to believe that proper mesendoderm differentiation and movement was 
inhibited (Branford and Yost, 2002). Taken together these observations were comparable 
to what we would expect in an anti-Xlefty context where Nodal activity occurs 
unregulated (Fig. 5).  
The PD, when co-injected with Xlefty was able to rescue an Xlefty over-expression 
phenotype 
 Rescue experiments by co-injecting 1ng/cell of PD mRNA with 25pg/cell Xlefty 
mRNA at the 4-cell stage determined that the PD was able to rescue Xlefty over-
expression (Fig. 9). Exogastrulation was absent in the co-injected embryos (0%, n=57), as 
well as a loss of ventral wrinkling (95%, n=57) [Fig. 10 and 11]. The result of this 
experiment demonstrates that the PD can rescue an Xlefty over-expression phenotype and 
led us to hypothesize that the PD regulates Mat-Xlefty function, possibly by interacting 
with it. 
. 
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Figure 5: Schematic of phenotypes observed in an anti-Xlefty and an Xlefty context. 
The published data, summarized in the schematic, provides a baseline with which subsequent 
phenotypes can be compared. 
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Figure 6. PD expression results in heart and gut reversals. 
500 pg of PD mRNA was microinjected into each cell of a 4-cell stage 
embryo. Hearts and guts were scored at stage 46 for reversals. (A) 46% of the 
embryos injected had reversed hearts. (B) 31% had heterotaxia and 12% had 
full reversals in gut development. Controls were uninjected. 
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Figure 7. The PD causes exogastrulation. 
(A) Schematic of the PD construct. The PD construct contains only the 
PD region. The molecule is tagged at the C-terminus with an HA tag. 
(B) Uninjected control embryo depicting normal phenotype. (C-F) PD 
microinjected embryos depicting exogastrulation (C), less than 50% 
dorsal closure (D), 50% or more dorsal closure (E) or full dorsal 
closure (F). (B, E and F) Anterior to left, lateral view. (C, D) Lateral 
views. 20X. 
 
16 
 
 
 
 
 
Figure 8. The PD causes a spectrum of dorsal closure loss. 
Uninjected embryos did not exhibit any exogastrulation (n=98). PD microinjected 
embryos had 60% exogastrulation (n=97). 
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Figure 9. The PD is able to antagonize an Xlefty overexpression phenotype.  
Spectrum of phenotypes seen when PD and Xlefty are overexpressed and co-expressed in the 
embryo. Xlefty PD mRNA was microinjected at 1ng/cell in each dorsal cell of a 4-cell stage 
embryo and Xlefty mRNA was injected at 25pg/cell in each dorsal cell of a 4-cell stage 
embryo. Xlefty PD mRNA (1ng/cell) was co-injected with Xlefty mRNA (25pg/cell) in each 
cell of a 4 cell stage embryo. (A) Uninjected controls. (B-D) Spectrum of PD-injected embryo 
phenotypes. (B) Exogastrulae. (C) <50% dorsal closure. (D) ≥50% dorsal closure. (E-G) 
Spectrum of Xlefty-injected embryos. (E) Bilateral eyes, ventral wrinkling. (F) Single eye, 
ventral wrinkling. (G) No eyes, ventral wrinkling. (H, I) Spectrum of PD+Xlefty-injected 
embryos. (H) Partial rescues which have ≥50% dorsal closure and rescue of eyes. (I) Fully 
rescued embryos. (A-I) Lateral view. (A, D-G, I) Anterior to left. (B) anterior to right. (C) 
Upper embryo anterior to left and lower to right. (H) Upper embryo anterior to right and lower 
to left. Embryos were scored and photographed at stage 36. 16X. 
 
Fig. 5 
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Figure 10. The PD co-injected with Xlefty rescues exogastrulation and dorsal 
closure.  
Uninjected embryos did not exhibit any exogastrulation (n=66). PD-microinjected 
embryos had 12% exogastrulation and 52% failure of complete dorsal closure (n=59). 
Xlefty microinjected embryos had 0% exogastrulation or dorsal closure failure (n=55). 
PD+Xlefty microinjected embryos exhibited no exogastrulation and 52% of the 
embryos had 100% dorsal closure (n=57), thus demonstrating rescue. 
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Figure 11. The PD co-injected with Xlefty rescues a ventral wrinkling phenotype. 
Uninjected embryos had no ventral wrinkling (n=66). 2% of the PD microinjected 
embryos had ventral wrinkling (n=59). In contrast, 100% of the Xlefty microinjected 
embryos had ventral wrinkling (n=55). Only 5% of the Xlefty+PD microinjected embryos 
had ventral wrinkling (n=57), thus demonstrating rescue. 
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The PD is able to co-immunoprecipitate (co-IP) mat-Xlefty but PDmut cannot  
 To begin to test if the PD inhibits Mat-Xlefty by interacting with it, we asked if 
the PD could co-immunoprecipitate (co-IP) Xlefty. To do so, mRNAs encoding the PD 
and Xlefty were co-injected into a 4-cell stage embryo at a concentration of 750pg for the 
PD and 250pg for Xlefty. Because antibodies against the native Xlefty and its mutated 
derivatives are not available, all Xlefty constructs were C-terminally tagged with a Myc 
epitope tag or a hemagglutinin (HA) epitope via standard PCR cloning protocols. The 
results showed that the PD is able to co-IP mat-Xlefty, but not uncleaved Xlefty (Fig. 13). 
This was consistent with our hypothesis that the PD regulates Xlefty by molecularly 
interacting with it. 
 A comparative analysis of 33 human TGFβ family members identified a 
conserved hydrophobic motif Hyd-Hyd-X-X-Hyd-X-Hyd within the PD (Fig.12) (Walton 
et al., 2009). This conserved site suggests that this region serves a common role in 
governing the assembly and secretion of TGFβ ligands (Walton et al., 2009). When 
deleted in TGFβ1, the association between the pro- and mature domains, in addition to 
secretion, were inhibited (Walton et al., 2009; Young and Murphy-Ullrich, 2004). Our 
comparison of the Xlefty prodomain to the consensus residues revealed, that in Xenopus, 
the hydrophobic motif is present (Fig. 12). In the Xlefty PD, it corresponds to amino 
acids 34, 35, 38 and 40 (Fig.12). These were mutated by PCR mutagenesis from 
hydrophobic leucines to alanines to maintain hydrophobicity thereby reducing the effect 
on folding of the protein but disrupting the putative binding site (Fig. 12). To test if these 
conserved residues facilitate the interaction between the PD and Mat-Xlefty, a co-IP 
experiment was performed by co-injecting 1ng/cell of PDmut mRNA with 250pg/cell 
Xlefty mRNA into 4 cell embryos. The results demonstrated that the PDmut was unable 
21 
 
to co-IP Mat-Xlefty (Fig. 13) and suggested that the interaction between the PD and Mat-
Xlefty was dependent on the mutated motif. 
22 
 
 
 
 
 
 
 
 
 
Figure 12. Xenopus lefty (Xlefty) shares a conserved hydrophobic motif with 33 
other TGFβ family members. 
A sequence alignment of the prodomains of 33 TGFβ family members was done using 
ClustalW by Walton et. al. They identified a conserved hydrophobic motif shown by the 
inverted parenthesis. We compared the Xlefty prodomain region (shown in green) that 
corresponds to the alignment and demonstrate that it was also conserved. The 
hydrophobic leucines highlighted were mutated to alanines in our PDmut. Adapted from 
Walton et. al. 2009. 
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Figure 13. The PD, but not the PDmut, can co-IP Xlefty. 
PD (A) is able to co-immunoprecipitate Xlefty but the PDmut (B) cannot. 2 cell Xenopus 
embryos were co-injected with RNAs encoding Xlefty-Myc and PD-HA or PDmut-HA. 
Embryonic extracts were immunoprecipitated with anti-HA antibodies and SDS-PAGE 
western blot analysis with anti-Myc antibodies was utilized to detect co-
immunoprecipitation of Xlefty-Myc. Red asterisks in all blots indicate uncleaved Xlefty, 
or its mutated derivatives. The yellow asterisks in all blots indicate Mat-Xlefty or its 
mutated derivatives. 
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PDmut does not cause exogastrulation yet weakly rescues Xlefty over-expression 
 Because PDmut was unable to co-IP Mat-Xlefty, we predicted that it would not 
inhibit Xlefty function. To test this, PDmut was microinjected at a concentration of 
1ng/cell into 4 cell stage embryos. In contrast to PD injection (Figs.7-9), exogastrulation 
was not observed and 88% of the embryos exhibited normal development (n=78) 
(Fig.14). This inability of PDmut to inhibit Xlefty was consistent with our prediction. 
We also tested if PDmut could rescue Xlefty over-expression. The PDmut was 
microinjected at a concentration of 1ng/cell into 4-cell stage and co-injected with Xlefty 
at a concentration of 1ng/cell for the PDmut and 25pg/cell for Xlefty at the 4-cell stage. 
For comparison, Xlefty was microinjected at a concentration of 25pg/cell at the 4-cell 
stage. The embryos were scored for normal blastopore (BP), delayed BP, no BP, and 
aberrant BP formation where the BP was either incomplete or not well defined.  
Loss of BP formation is a definitive phenotype seen in an Xlefty over-expression 
context (Fig. 5). The Xlefty-microinjected embryos had 88% with a loss of BP and 12% 
with aberrant BP formation, a less severe phenotype (Fig. 15). Embryos co-injected with 
PDmut and Xlefty resulted in 63% loss of BP and 37% with aberrant BP formation (Fig. 
15). Although there was not a complete rescue of the Xlefty phenotype, the co-injected 
embryos had fewer embryos exhibiting a complete loss of BP formation when compared 
to Xlefty alone. The increase in aberrant BP phenotypes in the co-injected embryos 
suggested that the PDmut had a weak ability to antagonize Xlefty. These results indicated 
that some interaction between Xlefty and PDmut might still occur.  
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Figure 14. PD causes exogastrulation but the PDmut does not. 
Schematics of PD-HA (A) and PDmut-HA (B) are compared where the PDmut-HA has 
mutations that change amino acid numbers 34, 35, 38, and 40 from leucines to alanines. 
(C) Uninjected controls. (D) PD-HA was microinjected at 1ng/cell into the dorsal cell of 
a 4-cell stage embryo and resulted in exogastrulation. (E) PDmut-HA was microinjected 
at 1ng/cell into the dorsal cell of a 4-cell stage embryo and resulted in normal 
gastrulation. (F) Western analysis of the C (control uninjected embryos), PD-HA 
microinjected embryos, and the PDmut-HA microinjected embryos showing the presence 
of the protein in the embryo lysates but not in the control. (G) Western analysis of 
secretion studies done on the PD. The first blot is the result of the PD secretion properties 
in an embryo assay showing no secretory product in the medium (Med) but presence of 
the PD in the lysate (Lys). The second blot is the result of the PD secretion properties in a 
cell culture assay showing no secretory product in the Med but presence of the PD in the 
Lys. (C, E) Dorsal view, anterior to top. (D) Lateral view, anterior to left. Embryos are at 
stage 14. 16X. 
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Figure 15. The PDmut weakly rescues Xlefty over-expression. 
The graph represents the percentage of embryos that had normal BP formation 
compared to delayed BP, no BP and aberrant BP formation. Xlefty-microinjected 
embryos had 88% with no BP and 12% with aberrant BP formation. Embryos co-
injected with PDmut and Xlefty had 63% with no BP and 37% with aberrant BP 
formation. The decrease in the loss of BP formation and the increase in the 
aberrant BP formation in the co-injected embryos suggest that the PDmut 
potentially still may interact with Xlefty. 
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PDmutXlefty over-expression is similar to Xlefty over-expression embryos 
 Our hypothesis states that the PD negatively regulates Xlefty and it might do so 
by molecularly interacting with it as seen by our rescue and co-IP studies. To further test 
this hypothesis, we created a full length Xlefty with the PDmut (PDmutXlefty) by PCR 
mutagenesis. We predicted that PDmutXlefty would have increased activity compared to 
wild-type Xlefty because inhibition by the PD should be attenuated in PDmutXlefty. 
 PDmutXlefty was tested by microinjecting 500pg/cell of PDmutXlefty into 2 cell 
stage embryos. The resulting phenotypes were compared with embryos microinjected 
with 500pg/cell of Xlefty (Fig. 16). Xlefty and PDmutXlefty microinjected embryos were 
scored for a lack of blastopore formation at stage 11 and both were observed to have 
similar numbers of embryos with lack of BP formation (Xlefty (%; n=75) and 
PDmutXlefty (%, n=79)). Uninjected control embryos were normal (n=80). Embryos 
were allowed to develop to stage 37/38 and no phenotypic disparity was apparent 
between the PDmutXlefty and Xlefty microinjected embryos (Fig. 16 E-G). Thus, our 
results do not demonstrate any difference in activity between Xlefty and PDmutXlefty. 
More quantitative assays of Xlefty activity might be necessary to detect any differences. 
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Figure 16. PDmutXlefty over-expression resembles Xlefty over-expression but its 
secretory properties do not. 
(A) Schematic of the PDmutXlefty-Myc showing the mutation where amino acids 34, 35, 38 and 40 were 
changed from leucines to alanines (B) Uninjected embryos at St. 11.5 showing normal blastopore formation 
(C) Xlefty microinjected embryos showed no blastopore formation. (D)  PDmutXlefty-Myc microinjected 
embryos showed no blastopore formation. (E) Uninjected embryos at St. 31 with normal development (F) 
Xlefty microinjected embryos showed typical Xlefty OE phenotype with ventral wrinkling, loss of anterior 
structures and stunting. (G) PDmutXlefty-Myc over-expression resembles Xlefty over-expression. (H) Western 
analysis of PDmutXlefty-Myc microinjected embryos revealed proper cleavage and presence of the two forms 
of Xlefty. (I) PDmutXlefty secretory properties tested using the cell culture assay showed the presence of Mat-
PDmutXlefty in the cell lysate but not in the medium. (B-D) Vegetal views. (E, F) Lateral views, anterior to 
right. (G) Lateral view, anterior to left. (B-D) 20X. (E-G) 16X. 
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Nodal-dependent mesodermal markers Goosecoid and Xbrachyury have an 
expanded expression pattern in PD over-expressing embryos compared to PDmut 
injected embryos 
 Our hypothesis posits that the PD negatively regulates Xlefty, thus we would 
predict an upregulation in Nodal signaling and subsequently in Nodal-dependent gene 
expression in PD injected embryos. To test this, we examined the expression of 
Goosecoid and Brachyury in PD injected embryos. Expansion in the Nodal-dependent 
expression of these two genes has previously been seen when an anti-Xlefty morpholino 
was used to block Xlefty (Branford and Yost, 2002). 
Goosecoid (Gsc) is a transcription factor that was isolated from the dorsal 
blastopore lip of the early Xenopus gastrula and plays a key role in patterning mesoderm 
in the early gastrula (Blumberg et al., 1991; Niehrs et al., 1994). At stage 10.25, Gsc is 
expressed at the dorsal blastopore lip and is confined to the immediate lip region, but in 
embryos microinjected with an anti-Xlefty morpholino this region expanded away from 
the lip (Branford and Yost, 2002). Similarly, when the PD was over-expressed, the 
expression pattern of Gsc was clearly expanded away from the boundaries observed in 
the uninjected embryos (n=16/20) (Fig. 17). 
 Brachyury (Bra) is a transcription factor that is necessary for the formation of 
posterior mesoderm and axial development. Xenopus brachyury (Xbra) is expressed 
transiently throughout the presumptive mesodermal tissue (Schulte-Merker and Smith, 
1995). At stage 10.5, Xbra is expressed at the boundary of the blastopore as a distinct 
tight ring that does not expand away from the blastopore, but in anti-Xlefty morpholino 
microinjected embryos, thickening of the ring and expansion away from the blastopore is 
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observed (Branford and Yost, 2002). In PD injected embryos, the Xbra ring of expression 
thickened and expanded away from the blastopore (n=10/10) (Fig. 17 D-F). 
The changes in the expression of Gsc and Xbra in PD injected embryos are 
indicative of expanded Nodal signaling and further support our hypothesis that the PD 
negatively regulates Xlefty activity. In contrast, the majority of the PDmut injected 
embryos did not exhibit changes in the expression patterns of Gsc (14/20) and Xbra 
(20/22) (Fig. 18). Taken together with the PD co-IP (Fig.13), this suggests that the 
residues mutated in PDmut are necessary for the PD-dependent regulation of Xlefty 
function. 
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Figure 17. PD over-expression alters Nodal-dependent gene expression. 
Induction of ectopic gsc and Xbra in the embryo by microinjection of PD. (A) Uninjected embryos with red arrowheads indicating 
limits of wild-type gsc expression at the blastopore lip. (B) PD-HA injected embryos with red arrow heads showed expansion of 
gsc expression beyond the boundaries of the blastopore lip. (C) Uninjected embryos with red arrowheads indicating Xbra 
expression on the periphery of the blastopore. (D) PD-HA injected embryos with red arrowheads showed Xbra expression has 
moved away from the periphery of the blastopore. (E) A lateral view of the uninjected embryos with red arrowheads indicated the 
boundary of the expression pattern of Xbra. (F) Lateral view of PD-HA injected embryos showed the expression pattern of Xbra 
and the expansion away from the periphery of the blastopore. (A-D) Vegetal view. (E, F) Lateral view. RNAs were injected into 
the animal pole cells of a 4-cell embryo and then embryos were fixed during gastrulation (St. 10.25 and St. 10.5) for in situ 
hybridization. (A-D) 16X. (E-F) 20X.  
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Figure 18. PDmut microinjection does not affect Nodal-dependent gene expression. 
(A) Schematic of the PDmut-HA showing the mutation where amino acids 34, 35, 38 and 40 
were changed from leucines to alanines. (B) Uninjected embryos were assessed for Xbra 
expression where the ring of staining could be seen around the periphery of the blastopore. 
(C) When compared to PDmut microinjected embryos there was not a visible shift in the 
expression pattern unlike PD-HA embryos seen in Fig.17. (D) Uninjected embryos were 
assessed for Gsc expression and normal Gsc expression was seen above the dorsal blastopore 
lip. (E) PDmut microinjected embryos revealed no difference in Gsc expression compared to 
uninjected embryos. Embryos were photographed at St. 10.25 for Gsc and St. 10.5 for Xbra. 
All embryos are vegetal views. (B, C) 20X. (D, E) 16X. 
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Cleavage of the Xlefty prodomain is a necessary prerequisite for proper function 
 Removal of the prodomain by SPCs has been shown to be a necessary 
prerequisite for normal functionality of the members of the TGFβ superfamily (Sengle et 
al., 2011). Lefty is an atypical member of the TGFβ superfamily and accordingly 
cleavage of its prodomain is necessary for it to function and properly antagonize Nodal 
signaling (Westmoreland et al., 2007). Xlefty has two canonical SPC cleavage sites 
located at amino acids 74-77 and amino acids 132-135 (Branford et al., 2000; Hamada et 
al., 2002; Westmoreland et al., 2007).As done previously, we mutated canonical cleavage 
site 1 from RXXR to GVDG and site 2 from RFHR to GVDG in addition to creating a 
double cleavage mutant that contains the two mutated cleavage sites. (Hamada et al., 
2002; Westmoreland et al., 2007). Our hypothesis was that the Xlefty PD is able to 
interact with the mature region of Xlefty and negative regulation by the PD would be 
exacerbated by these mutations since the PD would not be able to be cleaved.  
 Phenotypic analysis of embryos microinjected with the Xlefty cleavage mutants 
LCM1 (RKRRGVDG), LCM2 (RFHRGVDG) and an Xlefty double cleavage 
mutant L-DCM was performed by microinjecting 500pg of LCM into the left dorsal cell 
of a 4-cell embryo. Embryos were comparatively assessed with Xlefty microinjected 
embryos for loss of blastopore closure at stage 11, a distinctive phenotype seen in an 
Xlefty over-expression context (Fig. 5) (Branford and Yost, 2002). Consistent with what 
was seen in previous studies, the LCM2 and L-DCM had an Xlefty over-expression 
phenotype and no phenotype respectively. Briefly, 83% of the LCM2 microinjected 
embryos (n=96) microinjected embryos exhibited Xlefty over-expression suggesting that 
site 2 is not active in the embryo. The L-DCM did not affect the embryo and only had 
21% (n=97) loss of blastopore closure. We postulate that since the L-DCM has both sites 
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mutated it is rendered inert.  On the other hand, the LCM1 had some very interesting 
phenotypes. LCM1 had a 19% (n=92) loss of blastopore closure in comparison to Xlefty 
which had a 90% (n=95) loss of blastopore closure. Uninjected embryos had no 
prominent aberrations (n=98).  Phenotypes were also assessed at stage 28 and we noted 
that 60%  of the LCM1 injected embryos had a ventral bending phenotype that stunted 
the embryo (Fig. 19). Furthermore, LCM1 over-expression resulted in ventral wrinkling, 
a phenotype associated with Xlefty over-expression (Fig. 19) (Branford et al., 2000; 
Branford and Yost, 2002). These results were intriguing because previous studies 
reported a loss of Xlefty activity in the absence of PD cleavage (Westmoreland et al., 
2007). 
Lefty cleavage mutants (LCM) gives insight into the PD's regulatory role  
 Our results show that LCM1 has some weak activity while L-DCM is not active. 
The L-DCM has both the first and second cleavage site mutated unlike LCM1 which only 
has the first site mutated (Fig.20A). Taking this difference into account, we postulated 
that in LCM1 the second cleavage site may mediate Xlefty processing which results in a 
partially active protein. To assess this possibility, we examined LCM1 protein by western 
blot analysis (Fig. 20). For these studies mRNA was microinjected into a 2 cell stage 
embryo at a concentration of 500 pg, embryos were harvested at stage 11 and whole 
embryo extract was analyzed. As seen in Fig. 20B LCM1 was unable to be normally 
cleaved. However, a band was present immediately below the un-cleaved LCM1 
indicated by a yellow arrow in Fig. 20B. It is possible that site 2 could mediate some 
other type of post-translational modification that enable LCM1 to have some activity.  
Further studies are necessary to validate this observation. Unlike previous studies, we 
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report here that the LCM1 has some activity in the embryo and western analysis suggests 
that a processed protein is present that may mediate this activity. 
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Figure 19. L-CM1 (RKRRGVDG) exhibits function in X. laevis embryos.  
Embryos were microinjected with 500 pg mRNA in the left dorsal cell. (A) Normal 
uninjected embryos. (B) LCM1 injected embryos. (C) Xlefty injected embryos. (A-C) 
Stage 28 embryos. (A, C) Left lateral view, anterior to left. (B) Left lateral view (upper 
left and lower right embryos); right lateral view (upper right embryo); dorsal view (lower 
left embryo). Anterior to left (two lower and left upper embryos); anterior to right (upper 
right embryo). (A, C) 20X. (B) 16X. 
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Figure 20. The LCM1 is not cleaved and is not secreted.  
(A) Schematic of an Xlefty cleavage mutant 1 (LCM1). The active first cleavage site was mutated 
as indicated (LCM1 = RKRR to GVDG). At the N-terminus, a Myc tag was added since there is 
no available antibody that consistently detects Xlefty. (B) Western blot analysis on whole embryo 
extract reveals the inability of the LCM1 to be cleaved. Red asterisks in all blots indicate the Pro-
Xlefty protein (or its mutated derivatives) which still have the prodomain present. The yellow 
asterisks in all blots indicate Mat-Xlefty (or its mutated derivatives) which have had the 
prodomain cleaved. The yellow arrow in the LCM1-MYC is postulated to be a processed protein 
resulting from cleavage. (C) Results of the embryo secretion assay done on Xlefty and LCM1. 
The first blot is of Xlefty protein secretion demonstrating normal secretion of Mat-Xlefty seen in 
the medium. The second blot demonstrates LCM1 unable to be cleaved and no secretory products 
in medium. (D) Results of the cell secretion assay done on Xlefty and LCM1. The first blot is of 
Xlefty normal secretion with the Mat-Xlefty seen in the medium. The second blot is of the LCM1 
unable to be cleaved and no secretory product in the medium. GAPDH detection was used to 
demonstrate proof of principle of the secretion assay. GAPDH should not be detected in the 
medium. 
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An Xlefty with the PD removed (PDL) has weak activity 
 To further expand our analysis of the function of the PD, an Xlefty without the 
PD (PDL) was created by PCR mutagenesis. The PDL is an Xlefty with the PD domain 
removed but retaining the first 25 amino acids predicted to be the signal sequence 
cleavage site (SS) (as computationally determined using SignalP 3.0 Server). Our 
hypothesis is that since the PD is negatively regulating Mat-Xlefty once PD inhibition is 
removed (PDL) there would be no negative regulation and the PDL would behave in a 
strong Xlefty over-expression fashion. The PDL was over-expressed in the embryo by 
microinjecting 1ng/cell of a 4-cell embryo. Initial observations revealed that at St. 10.5 
PDL injected embryos were delayed in blastopore closure compared to uninjected 
controls (Fig. 21B-C). At stage 28, PDL microinjected embryos were observed to have a 
defect in eye formation. Defects in blastopore closure and eye formation are both 
consistent with Xlefty over-expression phenotypes (Branford et al., 2000; Branford and 
Yost, 2002) and suggest that the PDL has weak Xlefty activity. This is contrary to our 
hypothesis and indicates that the PD is necessary for more than just regulating Xlefty 
activity negatively. 
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Figure 21. The PDL when microinjected into 4-cell stage 
embryos results in delay of blastopore closure. 
(A) A schematic of the PDL protein. (B) Uninjected embryos at 
Stg. 10 and 10.5 respectively. The blue arrows point to the 
blastopore lip forming at St. 10 and already starting to close at 
stage 10.5. Both are vegetal views. 20X. (C) Graph depicting that 
embryos were delayed at St. 10 and were developing on time at 
10.5.  
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Figure 22. The PDL when microinjected into 4 cell stage embryos results in eye defects. 
(A) Spectrum of eye defects seen in embryos at St. 28. Top embryo is the uninjected control 
and has bilateral eyes (BE), followed by a single eye (SE), tiny eye (TE), cyclopic eye (CE) 
and no eye (NE). Yellow arrowheads indicate dorsally anterior region where the eyes or lack 
of can be seen. All are lateral views with anterior to the left. 16X. (B) Graph depicting 
number of embryos with eye defects.  
41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. The secretory properties of the PDL construct. 
(A) The PDL mRNA is translated when microinjected in the embryo. (B, C) The PDL is translated 
but not secreted in both the cell culture system (B) and the embryo secretion assay (C). GAPDH 
detection was used to demonstrate proof of principle of both assays. GAPDH is expected not to be 
found in the medium but present in the lysate. GAPDH also doubles as a loading control. 
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The secretory properties of Xlefty-mutated derivatives indicate that the PD may 
mediate proper Xlefty secretion 
 Given that TGFβ members signal extracellularly, including the secreted Nodal 
antagonist Xlefty, the secretory properties of the constructs that had a weak or no 
phenotype were investigated (Hill, 2001; Serra, 2008). The lack of phenotypes led us to 
postulate that mutations affecting the PD may impact secretion therefore constructs were 
assessed using an embryo and cell culture secretion assay.  
 Briefly, the embryo secretion assay was done by microinjecting mRNA into the 
left dorsal cell of 4-cell stage embryos. The embryos were left to develop until the 8-cell 
stage at which time the animal cap was punctured and embryos were incubated for 3-4 
hours. After this incubation period the conditioned medium and embryo lysates were 
collected for protein analysis. Briefly, the cell culture secretion assay used mouse 
embryonic fibroblast (MEF) cells that were transformed with plasmid DNA by the 
Nucleofection method. 4ug of plasmid DNA was transformed into MEF cells and the 
conditioned medium and cell lysates were collected at 24 and 48 hrs. 
Lefty cleavage mutants (LCM) gives insights into the PD's role in secretion 
 The secretory properties of the LCM1 were assessed by the embryo secretion 
assay. Embryos were microinjected with 600pg of Xlefty or LCM1 mRNA into the left 
dorsal cell. The results indicate that Xlefty-Myc is cleaved and present in the medium. In 
contrast, the LCM1 is not able to be cleaved and is not secreted. LCM1 was also assessed 
by the cell culture secretion assay where 4ug of Xlefty-Myc or LCM1 plasmid were 
transformed into MEF cells. The LCM1 was not observed in the cell medium but was 
clearly translated and present in the cell lysates (Fig. 20D). The results showed that the 
LCM1 was unable to be cleaved but its secretory properties were affected. The LCM1 
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has some activity in the embryo but its activity was probably limited because failure to 
cleave its PD seemed to affect secretion negatively. These results suggest that the PD 
plays a prominent role not only in regulating Xlefty function but also in mediating 
secretion. 
An Xlefty with the PD removed (PDL) is not secreted 
 The PDL was studied by over-expression and it was noted that besides delay of 
blastopore formation in early embryos and loss of eye at St.28 we did not observe strong 
Xlefty over-expression phenotypes. This was unexpected because our premise was that 
loss of the PD would remove inhibition and thus promote Xlefty over-expression. The 
lack of a strong Xlefty over-expression phenotype led us to look at the secretory 
properties of the PDL using both secretion assays. For the embryo secretion assay, 750pg 
of PDL mRNA was microinjected into the dorsal cell of 4 cell stage embryos. For the cell 
culture secretion assay, 4ug of PDL plasmid was transformed in MEF cells. Both 
secretion assays suggested that the PD has a role in the secretion of Mature-Xlefty since 
we did not see any processed form of the PDL in the secretion medium. 
The PD and the PDmutXlefty were not found to be secreted 
 Given the lack of secretion seen for our mutated constructs, we also tested if the 
PD was secreted (Fig. 14G). In both assays no secreted product was detected. The PDmut 
was tested in a cell culture secretion assay and secretion was not observed (results not 
shown). The absence of the PD or PDmut in the secreted medium was intriguing to us 
since we expected that the PD would be secreted because it caused severe phenotypes 
such as exogastrulation. It is possible that in the context of the secreted medium the PD 
and PDmut are easily degraded and would be undetectable by our assays. 
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 The PDmutXlefty was also tested in the cell culture secretion assay and the results 
showed the absence of PDmutXlefty processed forms in the secreted medium. This was 
interesting since the PDmutXlefty had a strong Xlefty over-expression phenotype and 
this suggests that it was most likely secreted. The mutations in the PDmut could 
potentially affect the stability of PDmutXlefty's processed forms in the secreted medium 
and further studies are necessary to test this.  
DISCUSSION 
The TGFβ superfamily is comprised of active signaling ligands that pattern the 
early embryo. Members of this superfamily include Nodal, BMP, Activin and Lefty. 
Lefty is considered an atypical member since it does not signal per se but its primary 
function is to antagonize the signaling capacity of Nodal. The mode of Lefty action is 
known, but so far there has not been any study that demonstrates the regulation of Lefty 
itself. In this study, we showed for the first time that Xenopus lefty (Xlefty) is regulated 
by its prodomain and that the prodomain also may play a role in proper Lefty secretion. 
A putative model of PD function in Xlefty regulation and secretion 
 Figure 24 is a schematic that shows our proposed model of PD regulation of 
Xlefty and its role in secretion. First, we show that a putative molecular interaction 
(indicated by dotted lines) occurs between the PD and Xlefty in either a pre-cleavage or a 
post-cleavage complex. Both forms result in negative regulation of Xlefty function. 
Xlefty's primary function is to antagonize Nodal signaling and our model shows that this 
is blocked. Secondly, our work on the secretory properties of Xlefty and its mutated 
derivatives suggest that the PD is a necessary core component that facilitates proper 
secretion (red arrow).  
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PD Over-expression Causes Anti-Xlefty Phenotypes and Can Rescue Xlefty Over-
expression Phenotypes 
 Over-expression of a PD alone construct (PD) at a concentration of 500pg per cell 
of a 2 cell embryo resulted in left right abnormalities in the embryos (Figure 6). Left-right 
abnormalities are indicative of dysregulated Nodal signaling so we increased the 
concentration of the PD to 1ng/cell in 4-cell stage embryos. 
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Figure 24. Model of PD role in regulation and secretion of Xlefty. 
This graphic illustrates our model that the PD interacts with the mature Xlefty peptide 
inhibiting normal functionality. This may be occurring in a pre-cleavage complex as 
indicated in the first complex with the cleavage site intact (black arrow) and the 
interaction present (dotted lines). The second complex is more likely with the PD 
interacting with the mature Xlefty in a post-cleavage complex. Both complexes have 
the capacity to block proper Xlefty function (red circle). Based on our work the PD is a 
core component in proper Xlefty secretion (red arrow).  
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 PD over-expression at this concentration resulted in exogastrulation, a phenotype 
we reported as a result of blocking Xlefty function with an anti-Xlefty morpholino (Fig. 
7) (Branford and Yost, 2002). This result suggested that the PD was inhibiting mature 
Xlefty function since targeting Xlefty with anti-Xlefty morpholino results in a similar 
phenotype (Branford and Yost, 2002). The phenotypes of PD-injected embryos also 
included loss of dorsal closure. They had varying degrees of dorsal closure and this 
suggests that there is a defect in convergent extension as a result of Nodal-expanded 
signaling which leads to unregulated mesodermal tissue expansion impeding dorsal 
closure (Fig. 8).  
 To examine whether the PD inhibits Xlefty, we tested if the PD could rescue 
Xlefty over-expression.  Co-injections with the PD and Xlefty were performed to test this 
(Fig. 9). Co-injecting both the PD and Xlefty demonstrated that the PD was able to rescue 
ventral wrinkling, an Xlefty OE phenotype (Fig. 9, 11). The PD was also able to rescue 
the open dorsal phenotype observed in PD alone injections (Fig. 7-10). This suggested 
that interaction between the co-injected PD and Xlefty resulted in most of the embryos 
having a "rescued" phenotype as seen in Fig. 9I.  
The PD co-IPs Xlefty: Evidence of a Molecular Interaction 
 The prodomains of other TGFβ family members have been shown to play an 
inhibitory regulatory role in TGFβ activity. Other studies suggest that the prodomain is 
able to sequester the mature ligand by binding to members of the extra-cellular 
membrane (Serra, 2008). The Xlefty PD, a protein of 77 amino acids, was co-injected 
with Xlefty and a co-IP experiment was carried out to test if the PD is able to interact 
with Xlefty molecularly (Fig. 13A). Seeing that the PD was able to co-IP the Mat-Xlefty 
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protein, this indicated that a molecular interaction occurs between the PD and Mat-
Xlefty.  
 A comparative analysis of the prodomain of 33 TGFβ family members was 
previously done and a conserved hydrophobic motif that constitutes four consensus 
amino acids was identified (Walton et al., 2009). We compared the prodomain region of 
Xenopus lefty (Xlefty) to the conserved motif and saw that this site was conserved in 
Xlefty as well (Fig. 12). We predicted that this site played a role in the PD-mature Xlefty 
interaction seen in the co-IP experiments. Based on what is known about other TGFβ 
ligands known to be secreted non-covalently bound to the PD, we predicted that mutation 
of this site would disrupt the interaction between the PD and Mat-Xlefty. PDmut, a PD 
with mutations at the aforementioned site, was made and co-injected with Xlefty and a 
co-IP experiment was carried out to test if the interaction was disrupted. The results of 
the co-IP experiments seen in Fig. 13 show that the PD has the capacity to co-IP Mat-
Xlefty while the PDmut cannot. These results are consistent with our hypothesis that the 
PD regulates Xlefty function by a molecular interaction, which we are just starting to 
understand. 
The PDmut is Unable to Rescue an Xlefty OE 
 The PDmut was also over-expressed in the embryo to test if there was any activity 
as was seen in the PD over-expression experiments. In a comparative analysis seen in 
Fig. 14 the PDmut was not seen to cause exogastrulation. The PDmut was also co-
injected with Xlefty to determine if it could rescue an Xlefty over-expression phenotype. 
The results demonstrated that the PDmut was not able to rescue the loss of blastopore 
formation fully, but was able partially to restore total loss of blastopore to aberrant 
blastopore formation (Fig. 15). These results led us to consider that it is possible for there 
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to be other relevant molecular interaction sites within the PD molecule that our mutations 
did not affect.  We propose that further investigation of other potentially important 
residues should be done. Western blot analysis of whole embryo extract of PD and 
PDmut microinjected embryos did not reveal any difference in protein concentration (Fig. 
14F).  
In situ hybridization of PD microinjected embryos suggests loss of antagonism of 
Nodal, further evidence of negative regulation of Xlefty by the PD 
 In the PD microinjected embryos, we studied the ectopic expression of Nodal-
dependent markers Goosecoid (Gsc) and Xbrachyury (Xbra) to ascertain if the PD was 
affecting Xlefty function. At stage 10.25, we observed significant expansion of Gsc away 
from the dorsal blastopore lip region as can be seen in Fig. 17B. At stage 10.5 Xbra was 
seen to expand farther away from the blastopore than the endogenous ring of Xbra in the 
control embryos (Fig. 17C-F). The expansion of endogenous Gsc and Xbra expression in 
the PD-expressing embryos and the subsequent exogastrulation of these embryos are 
consistent with the phenotypes previously seen with the injection of anti-Xlefty 
morpholinos (Branford and Yost, 2002).  
 The results of the PDmut in situ hybridization experiment in Fig. 18, demonstrate 
that the mutations in the PDmut prevented it from negatively regulating Xlefty, which did 
not alter the expression pattern of Nodal-dependent markers Gsc and Xbra. The 
observations of the PDmut in situ hybridization experiments led us to consider looking at 
the PDmut in the context of full length Xlefty. A PDmutXlefty construct was made that 
has all the characteristics of the Xlefty molecule but contains the mutations in the PDmut 
(Fig. 16). We expected to see the PDmutXlefty with a stronger Xlefty over-expression 
phenotype than un-mutated Xlefty since PD negative regulation would have been 
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removed. Our results showed that there was no phenotypic difference from the Xlefty 
over-expression phenotypes (Fig.16). Lefty, when compared to Nodal, has been shown to 
have higher mobility, thus we postulated that Xlefty and PDmutXlefty had comparable 
levels of activity in the embryo (Muller et al., 2012). It is possible that our over-
expression assay needs to be modified to tell if there was a difference in activity levels. 
The PD is more than meets the eye 
 TGFβ ligands have diverse roles such as cell cycle regulation, cell morphology 
and adhesion, ECM deposition and tissue differentiation (Serra, 2008). Our studies so far 
suggest that the versatility of the TGFβ superfamily members can be attributed to the 
regulatory functionality of the prodomain. Further studies, done on the secretory 
properties of Xlefty and its mutated derivatives, revealed that the PD is also necessary for 
proper secretion.  
Xlefty Cleavage Mutant 1 (LCM1) holds clues to the PD's role in secretion 
 Our initial investigation into the Lefty prodomain started with repeating a 
previous study on Lefty cleavage mutants (LCM). We mutated cleavage site 1 (LCM1), 
site 2 (LCM2) and made a double cleavage site mutant (DCM) and tested their functional 
and secretory properties as done previously (Sakuma et al., 2002; Westmoreland et al., 
2007). Phenotypic assessment of the cleavage mutants revealed that the DCM did not 
have activity and the LCM2 had phenotypes similar to Xlefty over-expression. However, 
LCM1 revealed interesting phenotypes unlike previously reported (Fig. 19). This led us 
to study the secretory properties of LCM1 and we demonstrated that prevention of 
cleavage affected the secretion properties of the LCM1 using both an embryo and cell 
culture assay (Fig.20). The LCM was not cleaved as seen in Fig.20B. When tested in both 
our assays and compared to un-mutated Xlefty, LCM1 was not secreted (Fig. 20C-D). 
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Inversely, the un-mutated Xlefty had both the unprocessed Pro-Xlefty and the processed 
Mat-Xlefty indicating cleavage (Fig. 20 C-D). Additionally, the processed Mat-Xlefty is 
seen in both the embryo and cell culture secreted medium thus demonstrating secretion of 
Mat-Xlefty but not uncleaved Xlefty. This is consistent with the processing of TGFβ 
ligands intracellularly and the requisite for proper secretion in some members (Harrison 
et al., 2011). It is probable that the LCM1 is unable to be secreted from the cell since the 
PD first has to be cleaved. Our model suggests that a molecular interaction is present in 
an extracellular context. Could this same molecular interaction be used to mediate a 
specific conformation that is required for Xlefty secretion?  
 Given that TGFβ secretion is dependent on non-covalent molecular interactions 
between the prodomain and the mature domain it is possible that this interaction could 
occur intracellularly (Walton et al., 2009). It is possible that the PD is a core component 
for a portion of the Xlefty secretory pathway but since the PD is still attached in LCM1 
the inhibitory non-covalent hydrophobic motif may be impeding proper secretion. The 
ventral bending phenotype seen in the LCM1 microinjected embryos could mean that the 
second cleavage site was mediating a processed form that requires further validation. We 
propose that a PDmut combined with a LCM1 mutant would reveal interesting results 
that could elucidate the dual mechanism behind the PD's negative regulation of Xlefty 
and its equally important role for proper Xlefty secretion. 
The PD and the PDmutXlefty are not secreted 
 We also studied the secretory properties of the PD itself and it was not found to be 
secreted in our secretion assays (Fig. 14). These results were unexpected since it is 
believed that cleavage of the PD occurs once Xlefty is secreted out of the cell and the 
spectrum of PD phenotypes seen would suggest secretion. Perhaps the PD was not 
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detectable in the media of our secretion assays due to sensitivity issues of the assay or 
when secreted, the PD is in a conformation that masks it from detection. The PD could 
also be unstable in the context of secreted media and thus would degrade rapidly upon 
secretion making it undetectable. 
The secretory properties of the PDmutXlefty were also studied and surprisingly a 
processed form was not detected in the medium (Fig.16). Our results show that the 
PDmutXlefty when microinjected, has similar phenotypes to Xlefty so we strongly 
believe that it is secreted. However, our cell secretion assay did not detect a secreted form 
in the medium. This finding suggests that the secretion assay is not sensitive enough 
since we detect translated PDmutXlefty from whole embryo extract. As previously 
mentioned, mutations in the PD may disrupt non-covalent binding sites that prevent 
proper secretion resulting in undetectable levels of processed PDmutXlefty in the 
secreted medium. 
A PD Less Lefty (PDL) mutant opens a Pandora's box 
 The results from my LCM1 study led to the construction of an Xlefty protein that 
lacks the PD domain named PD Less (PDL). This clone contains all the components of 
unaltered Xlefty, but is missing the domain after the signal sequence and immediately 
after the first cleavage site (Fig. 21). Our preliminary investigations revealed that PDL 
microinjected embryos had a delay in blastopore closure (Fig. 21). At stage 28 we saw 
that the embryos had defects in eye formation (Fig. 22). Our hypothesis suggested that 
the PDL would have a strong Xlefty over-expression phenotype since PD regulation is no 
longer there but we did not see this. At most, the PDL had a weak Xlefty activity leading 
us to look at the secretory properties of the PDL. The results showed that the PDL is not 
found to be secreted when tested with both the embryo and cell secretion assay (Fig. 23).  
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 These results along with the LCM1 results indicate that the PD is a necessary core 
component of Lefty secretory processing and function since mutations within the PD or 
the PD deletion constructs seem to abrogate proper secretion of Xlefty. This is 
paradoxical since many of the mutants looked at had phenotypic effects and we expected 
them to be secreted based on canonical behavior of other TGFβ family members. It 
appears that not only does the PD regulate Lefty function by interacting with it but it also 
plays a role in Lefty secretion. The results of the secretory studies suggest a previously 
unknown role of the Xlefty PD and warrant further investigation.  
The PD is a bio-molecule that presents a potential therapeutic application for the 
treatment of diseases caused by Nodal and Lefty mis-expression 
 Further studies are necessary since potential therapies to address malignancies can 
be devised based on Lefty's antagonism of Nodal. Studies have shown that exposure of 
tumor cells to Lefty leads to a downregulation of Nodal signaling resulting in reduced 
clonogenicity and tumorigenesis (Postovit et al., 2008). This along with the fact that 
Nodal can auto-induce its own transcription and also directly regulates that of Lefty led 
us to consider the regulatory mechanisms that govern Lefty functionality (Schier, 2009). 
Since its isolation, abnormal Lefty activity has been implicated in several diseased states 
in vertebrates, such as situs inversus in mice (Meno et al., 1996). Lefty was also isolated 
in the endometrial tissue and was named endometrial bleeding associated factor (ebaf) 
where it possibly regulates normal menstruation (Kothapalli et al., 1997). Further, 
investigations showed that dysregulation of ebaf was associated with abnormal 
endometrial bleeding (Tabibzadeh et al., 2000). 
 The role of prodomains in the TGFβ family are different from species to species, 
however their sequences have conserved residues between species (Derynck R., 2008). 
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For some of the members of the superfamily, the prodomain is non-covalently associated 
with its growth factor dimer in an inactive complex. For others, the prodomain/growth 
factor complex is active even though the prodomain is non-covalently associated with its 
growth factor dimer (Sengle et al., 2011). Here we have reported a mechanism by which 
the Xlefty prodomain may regulate the function of Xlefty and this represents a new study 
of prodomain functionality in the TGFβ signaling peptides. We believe that studies like 
these on the Lefty prodomain could potentially lead to the development of small bio-
molecule candidates with the capacity to prevent disease manifestations that arise from 
dysregulated cell-signaling pathways. 
Materials and Methods  
Frogs and embryo culture.  
 The frog colony was maintained in an Aquatic Habitats XR5 system (Apopka, 
FL) chilled by a Marine Biotech System (Apopka, FL) and kept according to Institutional 
Animal Care and Use Committee (IACUC) and Wayne State Universities Division of 
Laboratory Animal Resources (DLAR) facility standards. Embryos were obtained by in 
vitro fertilization, cultured in 1/3 Marc's modified Ringer's solution (MMR), and staged 
according to Nieuwkoop and Faber (P.D. Nieuwkoop, 1967).  
Microinjection. 
 Embryos were microinjected at 2 through 4 cell stage in 2.5% Ficoll in 1/3 MMR. 
Synthetic mRNAs were injected in the embryo with the location determined by 
experiment. All embryos used in these studies were staged using the Nieuwkoop and 
Faber Table of Xenopus laevis development (P.D. Nieuwkoop, 1967). For microinjection, 
a PLI-90 microinjection unit (Harvard Apparatus) fitted with an adjustable Narishige 
needle mount (Japan) was used. Total RNA concentrations for the different constructs 
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ranged from 25pg to 4ng. After microinjection embryos were left to develop in 1/3 MMR 
with 50ug/ml Gentamycin. For the embryo secretion assay 1/3 MMR was replaced with 
calcium free conditioned medium (CFCM). Uninjected controls as well as embryos 
microinjected with inert mRNA (GFP mRNA) at the same concentrations served as 
controls. Uninjected controls allowed us to show that there is no background phenotype 
in our wild type embryos. The use of GFP mRNA tests if our results are due to a high 
concentration of mRNA resulting in embryo toxicity. 
Plasmid constructs and synthetic RNA construction. 
 All constructs were generated by cloning into a pCS2+ vector. These were 
subsequently transformed into XL1 blue super-competent cells (Stratagene). Epitope 
tagged and mutant constructs were made by PCR mutagenesis. For pCS2+Lefty Cleavage 
Mutant 1st site and 2nd site and combined, the 1st and/or 2nd cleavage site were mutated 
from RXXR to GVDG using a Quick Change Site - Directed Mutagenesis Kit 
(Stratagene). Clones including pCS2+PD, pCS2+PDless, pCS2+PDmut and 
pCS2+PDmutXlefty were made using PCR mutagenesis. All constructs were sequenced 
to confirm the mutations. The 5' primer sequence used for the LCM first cleavage site 
amplification was 5' CTA TGC TGC ACA GTC ACA GAG AGG GGG TGG ATG GAT 
CAC TGC CCA GCT TGG CTG GC 3'; second cleavage site 5'  GAA CGT CCC AGA 
GAG GGG AGT CGA CGG ACC AGT CAG CAA TGC 3'; for the PDless forward 5' 
GAA GCC ATT GAT GGC AGC CAG GCA CAG GG 3'; reverse 5' TCA CTG CCC 
AGC TTG GCT GGC ATC CTC AG 3'; for the PDmut forward 5' GCT GCT GCT AAA 
AAA GCT AAC GCT CAA GAG GTT CCC AAA CTG GAG 3'; reverse 5' CTC TTG 
AGC GTT AGC TTT TTT AGC AGC AGC ATC TCT GAT GTT GTC AGG 3'; for the 
PD, 5’ GCT CTA GAT CAT CTC CTC TTC CTC TCT 3’; and for PD-HA, 5’ GCT 
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CTA GAT CAG GCA TAG TCT GGG ACG TCA TAT GGA TAT CTC CTC TTC 
CTC TCT CTG TG 3’. The 5’ primer sequence used for the amplification of Xlefty-HA 
was 5’ CGG GAT CCA GAA TGG GTG TCA CTA CCA 3’. The 3’ primer sequence for 
amplification of Xlefty-HA was 5’ ACG GGA TCC GTC AGG CAT AGT CTG GGA 
CGT CAT ATG GAT ATA TTA TAG CGA TAT TG 3’. Myc-tagged Xlefty was 
generated by amplifying the Xlefty cDNA from pCS2+Xlefty (5’ CGG GAT CCA GAA 
TGG GTG TCA CTA CCA 3’ and 5’CGG GAT CCT ATT ATA GCG ATA TTG TCC 
3’), digesting the product with BamHI and cloning it into pCS2+MT(Rupp et al., 1994; 
Turner and Weintraub, 1994). For all HA-tagged constructs, a single HA epitope was 
inserted at the C-terminus of Xlefty or its truncations. Capped mRNAs for microinjection 
were synthesized using the SP6 mMessage mMachine (Ambion) for pCS2+Xlefty and its 
mutated derivatives. For in situ hybridization, RNAs were transcribed with the 
MAXIscript protocols (Ambion).  
Protein quantification and analysis.  
 The mutated Xlefty mRNAs were microinjected to assess proper translation and 
stability by western blotting. Whole embryo protein extraction was done following 
similar methods as described in Yeo and Whitman (Yeo and Whitman, 2001). Following 
microinjection, ten embryos were harvested at stage 10.5 and homogenized by lysis in 1X 
lysis buffer (200ul 5X IP buffer [2.5ml Tris-HCL pH 7.5, 1.5ml 5M NaCl, 200ul 0.5M 
EDTA, 1.0ml 0.5M NaF, 4.7ml 106mM Na4P2O7, 100ul 0.1M Na3VO4], 100ul mini 
EDTA-free protease inhibitor solution (Roche), 50ul 10% Triton (FisherSci), 650ul 
H2O). Proteins were then quantified by using the Modified Lowry Protein Assay Kit as 
per the manufacturer's directions (Thermo Sci). Using an Xcell Surelock system 
(Invitrogen), gel electrophoresis of 10µl protein sample was run on an SDS-PAGE gel for 
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90 minutes at 125 volts. 10µl of uninjected control embryos served as negative controls. 
An Xcell blot module (Invitrogen) was used for blotting onto a polyvinylidene flouride 
(PVDF) transfer membrane (GE Healthcare). Western hybridization was carried out 
using rabbit anti-HA polyclonal primary antibody (Covance), anti-MYC (Covance) or 
anti-GAPDH (Millipore) followed by incubation with goat anti-rabbit (Jackson), rabbit 
anti-mouse (Covance) or mouse anti-rabbit secondary antibodies conjugated with  
hydrogen peroxidase (Covance). Detection was performed with the ECL Plus Western 
Blotting Detection System (GE Healthcare). 
Co-immunoprecipitation. 
 Embryos were harvested at stage 10.5 and lysed with 1X lysis buffer extracts and 
then incubated with 1:1000 primary antibody and rotated overnight in 4C. The following 
day proteins were incubated for two hours at RT rotating with Protein G Agarose plus 
slurry beads (Pierce). Samples were eluted by centrifugation for 2-3 minutes at 2,500 x g. 
This step was repeated several times with the supernatant being removed. Electrophoresis 
loading buffer (Fisher Sci) was added to the complex bound resin and incubated for 5 
minutes at 95
o
C. The contents were centrifuged and evaluated by SDS-PAGE using 
standard western blotting procedures (see above). 
Morphological studies 
 To begin characterizing the role of our mutated constructs in the embryo, the 
phenotype of the microinjected embryos over-expressing our study mRNA was assessed. 
Embryos were scored at gastrula (stage 10-11), neurula (stage 18-20) and later 
organogenesis stages (stage 36/38) using an MZ75 Leica Stereomicroscope. Embryos 
were fixed with 1X MEMFA (MEMFA salt 10X to make up 1X, 10% formaldehyde, 
H2O) overnight at 4
o
C and washed with PBS-T the following day. Embryos were placed 
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on an agarose-covered Petri dish and microphotographs were taken with a Leica MZ 16F 
fluorescent stereomicroscope mounted with a Leica DFC 425C color camera. At stage 
10-11 the embryos were scored for blastopore formation. Microinjected embryos were 
compared with uninjected controls to determine whether proper formation and 
development of the blastopore was occurring. At neurula stages the embryos were scored 
for proper neural fold fusion. At later stages, embryos were anesthetized with 0.01% 
benzocaine in culture media (1X MMR) and scored.  
 In situ hybridization. 
 In situ hybridization was carried out on Xenopus embryos as per the Early 
Development of Xenopus Embryo lab manual (Hazel L. Sive, 2000). Briefly, embryos 
were devitellinated and the blastocoel was pierced with a 16-gauge needlepoint (BD 
syringe). Embryos were transferred to a 5ml screw-cap glass vial (Fisher Sci) and fixed in 
MEMFA overnight at 4
o
C. Embryos were the stored the following day in ethanol at -
20
o
C. For hybridization, baskets were used for the subsequent steps. Embryos were 
permeabilized with Proteinase K followed by incubation overnight at 60
o
C in 
hybridization buffer containing probes at a concentration of probes for Nodal-dependent 
markers Goosecoid (Gsc) and Brachyury (Bra) were made by the suggested method in 
the Xenopus lab manual (Hazel L. Sive, 2000). Embryos were then rinsed with fresh 
hybridization and SSC buffer and treated with RNase A and RNase T. Embryos were 
washed in MAB buffer and then incubated overnight at 4
o
C in MAB containing 2% BMB 
blocking reagent with a 1/2000 dilution of the affinity-purified anti-digoxigenin antibody 
coupled to alkaline phosphatase. The following day the embryos were washed in MAB 
for five 1hr washes. The last wash was replaced with 4.5 ul/ml NBT and 3.5ul/ml BCIP. 
Staining took approximately five hours for our probes after which we refixed our 
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embryos in 4% paraformaldehyde overnight and stored them the following day in PBS-T. 
For microphotographs, uninjected embryos served as controls and embryos were placed 
in an agarose-covered Petri dish and microphotographs were taken with a Leica MZ 16F 
fluorescent stereomicroscope mounted with a Leica DFC 425C color camera. 
 Embryo secretion assay. 
 An in vivo secretion assay was developed to provide a method to test the secretory 
properties of Xlefty and its mutated derivatives. Embryos at the 4-cell stage were 
microinjected in the dorsal animal hemisphere blastomeres with mRNA encoding Xlefty 
or its mutant forms. The dorsal animal hemisphere blastomeres were targeted because 
cells from this region are fated to become the tissue that lines the roof of the blastocoel 
cavity (Moody, 1987). These cells then directly secrete protein products into their 
surrounding microenvironment including the blastocoel cavity. The blastocoel, a space 
within the embryo, forms during the blastula stage of development in Xenopus. During 
embryogenesis the blastocoel grows in size and is at its largest volume prior to 
gastrulation (stage 8-9). At stage 8-9, a small opening was made at the animal pole with 
fine tipped forceps to expose the blastocoel to the secretion-conditioned medium. At this 
point, the embryos are incubated in calcium-magnesium free media (CMFM) for 3 hours 
to allow for secretion. The CMFM prevents the opening in the embryo from healing, 
which would seal off the inner layer of cells responsible for secretion. The secreted 
protein products are then secreted into the conditioned medium and harvested at the end 
of the incubation period of 3 hours. At the end of the incubation time, the conditioned 
medium was collected and lysis buffer was added. Additionally the embryos are 
harvested, lysed, spun and the supernatant is collected. To test for debris in the secretion 
medium and to ensure that the result represented true secretion by the cells lining the 
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blastocoel roof, GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) (Millipore), a 
non-secreted protein found only in the nucleus and cytoplasm and not secreted, was 
tested as a control in the conditioned medium. 
 Cell culture secretion assay. 
 Mouse Embryonic Fibroblast (MEF) cells were cultured on DMEM (Dulbecco's 
Modified Eagle's Medium) (Gibco, Invitrogen) containing FBS (fetal bovine serum) 
(Invitrogen), and supplement (Invitrogen) on petri culture dishes (Fisher Sci). When cells 
were observed to be 75-80% confluent, cells were harvested by trypsinization (trypsin, 
Invitrogen) and transformation was carried out using the Nucleofection method (Lonza). 
After nucleofection the cells were cultured in a humidified incubator at 37
o
C, 5% C02 
(Fisher Sci) for 24 or 48 hours respectively. At both time points conditioned medium and 
cells were harvested by first removing the conditioned medium and adding 200ul 1X 
lysis buffer, followed by treating the cells with 200ul lysis buffer and incubating them for 
20 minutes at room temperature. Cells were then harvested by lifting the cells with a cell 
scraper (Invitrogen). Cells were then spun at 7000 Gs in a microcentrifuge at 4
o
C to 
remove all cell debris. Protein samples were stored at -80C until further analysis was 
warranted. 
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 In vertebrates, the TGFβ superfamily of secreted peptides are stringently 
regulated since they are responsible for multiple cell processes and behaviors that give 
rise to the proper patterning of embryonic tissues. Examples of members of the TGFβ 
superfamily are Nodal and Lefty. Dysregulation of these proteins can lead to many 
diseases and developmental syndromes in humans.  
 Lefty functions by antagonizing Nodal an essential organizer signal that patterns 
dorsal mesoderm and the embryonic axes. Loss of Lefty expression results in excess 
Nodal signaling which has been shown to cause several perturbations including 
metastatic cancer. Although studies have clearly shown that Lefty antagonizes Nodal 
signaling, there is a lack of understanding of the regulatory mechanism of Lefty itself. 
Previous studies have shown that proteolytic cleavage of the prodomain (PD) from 
mature Lefty (Mat-Lefty) is necessary for Lefty activity.  
 Here we present studies carried out using the Xenopus laevis embryo that 
demonstrate that PD over-expression causes exogastrulation, a phenotype also resulting 
from a loss of Xenopus Lefty (Xlefty) function.  Furthermore, when the PD and Xlefty 
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are co-expressed, the effects of Xlefty over-expression are rescued. Our biochemical 
studies also showed that the PD interacts with Mat-Xlefty but a PD mutated (PDmut) 
molecule does not. The sites mutated in the PDmut are evolutionarily-conserved residues 
that mediate the interaction between the prodomain and the mature ligand in other TGFβ 
proteins making our results consistent with previously observed behavior of TGFβ 
prodomains but new to Lefty. Our study also shows that the PDmut is unable to rescue 
the effects of a Xlefty over-expression phenotype unlike the un-mutated PD.  
 In addition we show here that mutations of the PD affect the secretion of these 
Xlefty-mutated derivatives. Taken together, these results suggest that the PD negatively 
regulates Xlefty activity by interacting with Mat-Xlefty and cleavage of the PD releases 
regulation allowing proper secretion and function. This new insight into the regulatory 
role of the Xlefty PD provides potential therapeutic value to address dysfunctional Nodal 
signaling. Furthermore, our secretion studies of the PD and Xlefty revealed that Xlefty is 
secreted but the PD is not. The Xlefty-mutated derivatives, including a PD Less, Xlefty, 
Xlefty cleavage mutants and the PDmut, resulted in no secreted products. These secretion 
results open a Pandora's box and further studies are warranted to elucidate the mechanism 
of PD regulation of Xlefty and whether it occurs in an intracellular or extracellular 
context.  
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